Hall J. M., M. K. Lee, B. Newman, J. E. Morrow, L. A. Anderson, B. Huey, and M. C. King. 1990. Linkage of early-onset familial breast cancer to chromosome 17q21. Science. 250 (4988):1684-1689.

Heller, M. A., and R S. Eisenberg. 1998. Can patents deter innovation? The anticommons in biomedical research. Science. 280(5364):698-701.

Henry, M. R., M. K. Cho, M. A. Weaver, and J. F. Merz. 2002. DNA patenting and licensing. Science. 297(5585):1279.

Hollen, T. 2000. NIH researchers receive cut-price BRCA test. Nat. Med. 6(6):610.

Howlett, M., and A. F. Christie. 2004. An analysis of the approach of the European, Japanese, and United States patent offices to patenting partial DNA sequences (ESTs). University of Melbourne Faculty of Law, Legal Studies Research Paper No. 82. Available at ssrn.com/abstract=573184.

Hughes, S. S. 2001. Making dollars out of DNA. The first major patent in biotechnology and the commercialization of molecular biology, 1974-1980. Isis. 92(3):541-75.


Jensen, K., and F. Murray. 2005. IP Landscape of the Human Genome. Science. 310:239-240.

Johnson, R. P., and A. Kaur. 2005. HIV: viral blitzkrieg. Nature. 434(7037):1080-1081.


Kastan, M. B., and J. Bartek. 2004. Cell-cycle checkpoints and cancer. Nature. 432(7015):316-323.

Kaufman, R. J. 1989. Genetic engineering of factor VIII. Nature. 342(6246):207-208.

Kaul R., G. P. Gao, K. Balamurugan, and R. Matalon. 1993. Cloning of the human aspartoacylase cDNA and a common missense mutation in Canavan disease. Nat. Genet. 5(2):118-123.

Kendrew, J. C., G. Bodo, H. M. Dintzis, R. G. Parrish, H. Wyckoff, and D. C. Phillips. 1958. A three-dimensional model of the myoglobin molecule obtained by x-ray analysis. Nature. 181(4610):662-666.

Kenney, M. 1986. Biotechnology: The University-Industry Complex. New Haven: Yale University Press.

Kilpatrick, M. M., D. W. Lowry, A. D. Firlik, H. Yonas, D. W. Marion. 2000. Hyperthermia in the neurosurgical intensive care unit. Neurosurgery. 47(4):850-856.

Kodish, E., T. Murray, and P. Whitehouse. 1996. Conflict of interest in university-industry research relationships: realities, politics, and values. Acad. Med. 71(12):1287-1290.

Kristiansen, O. P., Z. M. Larsen, and F. Pociot. 2000. CTLA-4 in autoimmune diseases–a general susceptibility gene to autoimmunity? Genes Immun. 1(3):170-84.


Lander, E. S., L. M. Linton, B. Birren, C. Nusbaum, M. C. Zody, et al. 2001. Initial sequencing and analysis of the human genome. Nature. 409(6822):860-921.

Lawrence, S. 2004. U.S. biopatents decline. Nat. Biotechnol. 22(7):797.


MacDonald, M. E., C. M. Ambrose, M. P. Duyao, R. H. Myers, C. Lin, et al. 1993. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes. The Huntington’s Disease Collaborative Research Group. Cell. 72(6):971-983.

Merz, J. F. 1999. Disease gene patents: Overcoming unethical constraints on clinical laboratory medicine. Clin. Chem. 45(3):324-330.

Merz, J. F., and M. K. Cho. 1998. Disease genes are not patentable: a rebuttal to McGee. Camb. Q. Healthc. Ethics. 7:425-428.

Merz, J. F., D. G. Leonard, A. G. Kriss, and M. K. Cho. 2002. Industry opposes genomic legislation. Nat. Biotechnol. 20(7):657.

Michelsohn, A. M. 2004. Biotechnology Innovation Report 2004: Benchmarks. Washington, D.C.: Finnegan, Henderson, Farabow, Garrett & Dunner, LLP.

Milstein, C. 1993. Patents on scientific discoveries are unfair and potentially dangerous. The Scientist. 7(21):11.

Mowery, David, Frichard Nelson, Bhaven Sampat, and Arvids Ziedonis. 2004. Ivory Tower and Industrial Innovation: University-Industry Technology Transfer Before and After the Bayh-Dole Act. Stanford University Press.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement